Mohan P. Devbhandari
Research Subjects
Research Interests
Mohan P. Devbhandari has a total of 35 co-authors. Here are the top co-authors by number of shared publications:
- Mark T Jones
Department of Cardiothoracic Surgery, Wythenshawe Hospital,Manchester,UK. M23 9LT
2 shared publications Mark T. Jones
Department of Cardiothoracic Surgery, University Hospital of South Manchester, Southmoor Road, Manchester M23 9LT, UK
2 shared publicationsPiotr Krysiak
Department of Cardiothoracic Surgery, University Hospital of South Manchester, Southmoor Road, Manchester M23 9LT, UK
2 shared publications- Piotr Krysiak
Department of Cardiothoracic Surgery, Wythenshawe Hospital, Manchester, UK
2 shared publications Rajesh Shah
Department of Cardiothoracic Surgery, University Hospital of South Manchester, Southmoor Road, Manchester M23 9LT, UK
2 shared publications- Ben Bridgewater
South Manchester University Hospital, Manchester, UK
1 shared publication
Latest Publications
- Open Access
- 5 August 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 180
Results of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre’s experience
Surgery for pulmonary aspergillosis is infrequent and often challenging. Risk assessment is imprecise and new antifungals may ameliorate some surgical risks. We evaluated the medical and surgical management of these patients, including perioperative and postoperative antifungal therapy.
- 5 August 2013
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 8 (1) , 180
Open AccessResults of surgery for chronic pulmonary Aspergillosis, optimal antifungal therapy and proposed high risk factors for recurrence - a National Centre’s experience
Surgery for pulmonary aspergillosis is infrequent and often challenging. Risk assessment is imprecise and new antifungals may ameliorate some surgical risks. We evaluated the medical and surgical management of these patients, including perioperative and postoperative antifungal therapy.
- Open Access
- 11 June 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 11 (4) , 411-414
Active treatment rates for lung cancer in south Manchester: are we doing enough?
In an effort to improve the current lung cancer treatment outcomes in Britain, National guidelines were published followed by the introduction of National Lung Cancer Audit (LUCADA) project. LUCADA has defined active treatment as any therapeutic intervention with the aim of improving the quality or length of patients' survival irrespective of whether it is curative or palliative. From August 2003 to December 2006, all patients diagnosed to be new primary lung cancer referrals were enrolled into a prospective study. Out of the total of 433 patients the majority of patients were male (62%) and the mean age was 69 years. The histologies were small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) and other cancers in 67 (15.5%), 306 (70.7%) and 11 (2.5%) patients, respectively, while 49 (11.3%) patients had no histological confirmation. Overall, the active treatment rate was 72% with 74 (18%), 158 (36%), 66 (15%) and 11 (3%) undergoing surgery, chemotherapy, radiotherapy and other methods, respectively. The active treatment rates for histologically proven SCLC, NSCLC and all lung cancers excluding SCLC were 83%, 77% and 71%, respectively, compared to the LUCADA national average of 73.5%, 66% and 56.5%, respectively. Among the NSCLC patients overall five-year survival was 27.4%. The stage specific survivals were 64.0%, 58.3%, 24.1% and 11.5%, respectively, for stages I, II, III and IV. These reassuring results show that south Manchester has good active treatment rates for lung cancer with survival outcomes comparable to other major series.
- 11 June 2010
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 11 (4) , 411-414
Open AccessActive treatment rates for lung cancer in south Manchester: are we doing enough?
In an effort to improve the current lung cancer treatment outcomes in Britain, National guidelines were published followed by the introduction of National Lung Cancer Audit (LUCADA) project. LUCADA has defined active treatment as any therapeutic intervention with the aim of improving the quality or length of patients' survival irrespective of whether it is curative or palliative. From August 2003 to December 2006, all patients diagnosed to be new primary lung cancer referrals were enrolled into a prospective study. Out of the total of 433 patients the majority of patients were male (62%) and the mean age was 69 years. The histologies were small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) and other cancers in 67 (15.5%), 306 (70.7%) and 11 (2.5%) patients, respectively, while 49 (11.3%) patients had no histological confirmation. Overall, the active treatment rate was 72% with 74 (18%), 158 (36%), 66 (15%) and 11 (3%) undergoing surgery, chemotherapy, radiotherapy and other methods, respectively. The active treatment rates for histologically proven SCLC, NSCLC and all lung cancers excluding SCLC were 83%, 77% and 71%, respectively, compared to the LUCADA national average of 73.5%, 66% and 56.5%, respectively. Among the NSCLC patients overall five-year survival was 27.4%. The stage specific survivals were 64.0%, 58.3%, 24.1% and 11.5%, respectively, for stages I, II, III and IV. These reassuring results show that south Manchester has good active treatment rates for lung cancer with survival outcomes comparable to other major series.
- Open Access
- 18 September 2008
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 8 (1) , 164-165
Emergency redo mitral valve replacement and caesarean section in a patient with previous atrioventricular septal defect repair in childhood
A 19-year-old primigravida, with a history of mechanical mitral prosthesis at the age of six years following previous repair of an atrioventricular septal defect, presented at 26 weeks' gestation with cardiogenic shock secondary to obstruction of the mitral prosthesis. She underwent successful emergency redo mitral valve replacement and caesarean section. At operation the prosthesis was found to be virtually completely obstructed with pannus. Both mother and baby had an excellent outcome following surgery. The case report is presented with a brief review of the literature.
- 18 September 2008
- Published by Oxford University Press (OUP) in Interactive CardioVascular and Thoracic Surgery
- Vol. 8 (1) , 164-165
Open AccessEmergency redo mitral valve replacement and caesarean section in a patient with previous atrioventricular septal defect repair in childhood
A 19-year-old primigravida, with a history of mechanical mitral prosthesis at the age of six years following previous repair of an atrioventricular septal defect, presented at 26 weeks' gestation with cardiogenic shock secondary to obstruction of the mitral prosthesis. She underwent successful emergency redo mitral valve replacement and caesarean section. At operation the prosthesis was found to be virtually completely obstructed with pannus. Both mother and baby had an excellent outcome following surgery. The case report is presented with a brief review of the literature.
- 1 September 2008
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 34 (3) , 479-483
Implications of a negative bronchoscopy on waiting times to treatment for lung cancer patients: results of a prospective tracking study☆
To ascertain the causes of delays in treatment to all patients presenting to our centre with a working diagnosis of lung cancer. All were entered prospectively into a 'tracking study'. Of 342 consecutive confirmed cases of newly diagnosed lung cancer presenting between September 2003 and December 2005, 193 were general practitioner referrals and 149 presented through casualty and internal referrals. The former group formed the basis of the study. Of GP referral patients, 92 had a positive diagnostic bronchoscopy (group Bronch+). Their waiting times were compared with 94 others with negative result (group Bronch-). For uniformity of comparison the non-GP referral patients were excluded from this study. There were no significant differences in the age, clinical presentation or clinical staging of the two groups. Bronch+ had higher proportion of male patients (p=0.05). Bronch+ group had higher proportion of small cell and squamous cell carcinoma whereas Bronch- group had higher prevalence of adenocarcinoma (p=0.02). More patients in Bronch- underwent curative (36 vs 18, p=0.01) intent treatment. Though the median intervals (days) between the referral to first chest outpatient appointments were similar between the two groups (1 vs 1, p=0.89), the intervals from out-patient to decision-to-treat (33 vs 57, p=0.001) and decision-to-treat to treatment (8 vs 12, p=0.05) were significantly longer for Bronch- group. Overall the median referral to treatment interval for Bronch- was significantly longer compared to Bronch+ (45 vs 75, p=0.001). Most of these delays occurred in the intervals from outpatient appointments to decision-to-treat. A negative initial bronchoscopy in a suspected lung cancer patient implies a greater potential for excessive delays in diagnosis and treatment in spite of a greater chance of curative treatment. Most of the delay occurs in the interval from the outpatient appointment to decision-to-treat. Patients with negative bronchoscopy require a more concerted effort to achieve a timely diagnosis and treatment.
- 1 September 2008
- Published by Oxford University Press (OUP) in European Journal of Cardio-Thoracic Surgery
- Vol. 34 (3) , 479-483
Implications of a negative bronchoscopy on waiting times to treatment for lung cancer patients: results of a prospective tracking study☆
To ascertain the causes of delays in treatment to all patients presenting to our centre with a working diagnosis of lung cancer. All were entered prospectively into a 'tracking study'. Of 342 consecutive confirmed cases of newly diagnosed lung cancer presenting between September 2003 and December 2005, 193 were general practitioner referrals and 149 presented through casualty and internal referrals. The former group formed the basis of the study. Of GP referral patients, 92 had a positive diagnostic bronchoscopy (group Bronch+). Their waiting times were compared with 94 others with negative result (group Bronch-). For uniformity of comparison the non-GP referral patients were excluded from this study. There were no significant differences in the age, clinical presentation or clinical staging of the two groups. Bronch+ had higher proportion of male patients (p=0.05). Bronch+ group had higher proportion of small cell and squamous cell carcinoma whereas Bronch- group had higher prevalence of adenocarcinoma (p=0.02). More patients in Bronch- underwent curative (36 vs 18, p=0.01) intent treatment. Though the median intervals (days) between the referral to first chest outpatient appointments were similar between the two groups (1 vs 1, p=0.89), the intervals from out-patient to decision-to-treat (33 vs 57, p=0.001) and decision-to-treat to treatment (8 vs 12, p=0.05) were significantly longer for Bronch- group. Overall the median referral to treatment interval for Bronch- was significantly longer compared to Bronch+ (45 vs 75, p=0.001). Most of these delays occurred in the intervals from outpatient appointments to decision-to-treat. A negative initial bronchoscopy in a suspected lung cancer patient implies a greater potential for excessive delays in diagnosis and treatment in spite of a greater chance of curative treatment. Most of the delay occurs in the interval from the outpatient appointment to decision-to-treat. Patients with negative bronchoscopy require a more concerted effort to achieve a timely diagnosis and treatment.
- Open Access
- 30 May 2008
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 3 (1) , 34
Long-term event-free survival with an embolised prosthetic valve leaflet in the thoracic aorta
We report the case of a patient who underwent a redo surgery for a leaflet escape from a Bjork-Shiley tilting disc mitral prosthesis inserted 18 years previously. The escaped disc remained lodged in the thoracic aorta without any complication. She ultimately died of terminal heart failure 13 years after the second operation. We believe this to be the longest survival with a dislodged leaflet from a mechanical valve. Removal of dislodged disc is recommended in literature but there may be a place for watchful observation in exceptional cases with no haemodynamic compromise.
- 30 May 2008
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 3 (1) , 34
Open AccessLong-term event-free survival with an embolised prosthetic valve leaflet in the thoracic aorta
We report the case of a patient who underwent a redo surgery for a leaflet escape from a Bjork-Shiley tilting disc mitral prosthesis inserted 18 years previously. The escaped disc remained lodged in the thoracic aorta without any complication. She ultimately died of terminal heart failure 13 years after the second operation. We believe this to be the longest survival with a dislodged leaflet from a mechanical valve. Removal of dislodged disc is recommended in literature but there may be a place for watchful observation in exceptional cases with no haemodynamic compromise.
- Open Access
- 24 July 2007
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 2 (1) , 34
Primary cardiac sarcoma: reports of two cases and a review of current literature
Primary cardiac sarcomas are rare tumors with an unfavourable prognosis. Complete surgical resection is currently the only mode of therapy proven to show any benefit. We report the cases of two patients presenting with features of obstruction and embolism and a presumed diagnosis of left atrial myxoma. At operation they were unexpectedly found to have large tumours raising strong suspicions of malignancy. Due to the extensive involvement of intracardiac structures with little possibility of reconstruction together with poor general condition of the patient, debulking was deemed to be the only viable option. Subsequent histology confirmed the diagnosis of sarcoma in both patients. Surgery produced immediate and effective symptom relief. The first patient died four months after the operation and second patient is still alive at 12 months after her operation. A brief review of literature on cardiac sarcoma is presented.
- 24 July 2007
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 2 (1) , 34
Open AccessPrimary cardiac sarcoma: reports of two cases and a review of current literature
Primary cardiac sarcomas are rare tumors with an unfavourable prognosis. Complete surgical resection is currently the only mode of therapy proven to show any benefit. We report the cases of two patients presenting with features of obstruction and embolism and a presumed diagnosis of left atrial myxoma. At operation they were unexpectedly found to have large tumours raising strong suspicions of malignancy. Due to the extensive involvement of intracardiac structures with little possibility of reconstruction together with poor general condition of the patient, debulking was deemed to be the only viable option. Subsequent histology confirmed the diagnosis of sarcoma in both patients. Surgery produced immediate and effective symptom relief. The first patient died four months after the operation and second patient is still alive at 12 months after her operation. A brief review of literature on cardiac sarcoma is presented.
- Open Access
- 12 January 2007
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 2 (1) , 5
UK waiting time targets in lung cancer treatment: are they achievable? Results of a prospective tracking study
- 12 January 2007
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 2 (1) , 5
Open AccessUK waiting time targets in lung cancer treatment: are they achievable? Results of a prospective tracking study
- Open Access
- 30 June 2005
- Published by Springer Nature in BMC Surgery
- Vol. 5 (1) , 16
Benign gastro-bronchial fistula – an uncommon complication of esophagectomy: case report
Background: Gastro-bronchial fistula (GBF) is a rare and devastating complication following esophagectomy. Making the correct diagnosis is difficult and there is no agreement on the treatment for this rare condition. Case presentation: We report the case of a 56-year-old man who presented with features of repeated aspiration and chest infections six years following an esophagectomy for Barrett's esophagus. Despite extensive investigations the cause of symptoms was difficult to determine. The correct diagnosis of fistula from stomach to right main stem bronchus was made at bronchoscopy under general anesthesia. After ruling out local recurrence of cancer, a successful primary repair was carried out by resection of fistula and direct repair of gastric conduit and bronchus. He is well after 6 months of treatment. Conclusion: Late development of gastro-bronchial fistula is a rare complication of esophageal resection that may be difficult to diagnose. Surgical resection and direct closure is the treatment of choice, although the method of treatment should be tailored according to the anatomy of the fistula and the patient's condition.
- 30 June 2005
- Published by Springer Nature in BMC Surgery
- Vol. 5 (1) , 16
Open AccessBenign gastro-bronchial fistula – an uncommon complication of esophagectomy: case report
Background: Gastro-bronchial fistula (GBF) is a rare and devastating complication following esophagectomy. Making the correct diagnosis is difficult and there is no agreement on the treatment for this rare condition. Case presentation: We report the case of a 56-year-old man who presented with features of repeated aspiration and chest infections six years following an esophagectomy for Barrett's esophagus. Despite extensive investigations the cause of symptoms was difficult to determine. The correct diagnosis of fistula from stomach to right main stem bronchus was made at bronchoscopy under general anesthesia. After ruling out local recurrence of cancer, a successful primary repair was carried out by resection of fistula and direct repair of gastric conduit and bronchus. He is well after 6 months of treatment. Conclusion: Late development of gastro-bronchial fistula is a rare complication of esophageal resection that may be difficult to diagnose. Surgical resection and direct closure is the treatment of choice, although the method of treatment should be tailored according to the anatomy of the fistula and the patient's condition.
- 8 April 2003
- Published by Elsevier in Cardiovascular Surgery
- Vol. 11 (3) , 243-245
Aortic pseudoaneurysm complicating sternal wound infection following CABG.
- 8 April 2003
- Published by Elsevier in Cardiovascular Surgery
- Vol. 11 (3) , 243-245
Aortic pseudoaneurysm complicating sternal wound infection following CABG.